Merck KGaA: Top-line results of peg IFN beta-1a from Biogen show competitive profile in the IFN world

NEUTRAL, Fair Value EUR100 (-2%)

News published on January Friday 25, 2013
Share on

The Essentials

Everything you need to know about investment banking dedicated to growth
Stay Informed
Get our news
Join our Team
Bryan, Garnier & Co is always looking for talent in all our divisions, at all levels
Explore our opportunities